A call for standardized naming and reporting of human ESC and iPSC lines

Authors

Mai X. Luong, University of Massachusetts
Jonathan Auerbach, GlobalStem
Jeremy M. Crook, St Vincent's HospitalFollow
Laurence Daheron, Harvard iPSC Core Facility
Derek Hei, Waisman Clinical Biomanufacturing Facility
Geoffrey Lomax, California Institute for Regenerative Medicine (CIRM)
Jeanne F. Loring, Scripps Research Institute
Tenneille Ludwig, WiCell Research Institute
Thorsten M. Schlaeger, Boston Children's Hospital
Kelly P. Smith, University of Massachusetts
Glyn N. Stacey, Medicines And Healthcare Products Regulatory Agency (MHRA)
Ren-He Xu, University of Connecticut
Fanyi Zeng, Shanghai Jiao Tong University

RIS ID

92436

Publication Details

Luong, M. X., Auerbach, J., Crook, J. M., Daheron, L., Hei, D., Lomax, G., Loring, J. F., Ludwig, T., Schlaeger, T. M., Smith, K. P., Stacey, G., Xu, R. & Zeng, F. (2011). A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell, 8 (4), 357-359.

Abstract

Human embryonic and induced pluripotent stem cell lines are being generated at a rapid pace and now number in the thousands. We propose a standard nomenclature and suggest the use of a centralized database for all cell line names and a minimum set of information for reporting new derivations.